Home Journals Articles Updates About
CN
image
收藏切换
Enhanced Near-Infrared-Excitable Organic Afterglow Nanoparticles for Deep-Tissue Multimodal Imaging via Singlet Oxygen-Mediated Energy Transfer
收藏切换
PDF
Yuzhen Yu, Zhe Li, Shiyi Liao, Baoli Yin, Qingpeng Zhang, Jiaqi Fu, Cheng Zhang*, Ying Zhou*, Guosheng Song*
Research. Vol 8 Article ID 0834
Less
收藏切换
Research. Vol 8 Article ID 0834
• Research Article •
Enhanced Near-Infrared-Excitable Organic Afterglow Nanoparticles for Deep-Tissue Multimodal Imaging via Singlet Oxygen-Mediated Energy Transfer
Full
Yuzhen Yu, Zhe Li, Shiyi Liao, Baoli Yin, Qingpeng Zhang, Jiaqi Fu, Cheng Zhang*, Ying Zhou*, Guosheng Song*
Affiliations
  • State Key Laboratory of Chemo and Biosensing, College of Chemistry and Chemical Engineering, Hunan University, Changsha 410082, China.
About Author:

† These authors contributed equally to this work.

Published: 2025-08-20 doi: 10.34133/research.0834
Outline
收藏切换

Afterglow imaging offers exceptional signal-to-background ratios (SBRs) by circumventing real-time excitation and autofluorescence, yet conventional systems rely on visible-light excitation, limiting tissue penetration and signal intensity. Here, we report near-infrared-excitable organic afterglow nanoparticles (NOANPs) that leverage singlet oxygen (1O2)-mediated energy transfer to achieve prolonged, high-intensity emission with minimal photobleaching. The nanoparticles integrate a near-infrared-photoactive sensitizer (NAM-0), which generates abundant 1O2 under 808-nm laser excitation, and a triplenet-anthracene derivative (TD) as the afterglow substrate, which converts 1O2 into sustained luminescence. Co-encapsulation via one-step nanocoprecipitation ensures proximity between NAM-0 and TD, enabling efficient energy transfer and yielding exceptional afterglow brightness (>109 photons/s) at ultralow concentrations (10 μg/ml). NOANPs enable deep-tissue imaging (up to 3.0 cm ex vivo) by synergizing the superior penetration of near-infrared light with organic afterglow chemistry. The nanoparticles uniquely support three imaging modes: fluorescence, white light-activated afterglow, and near-infrared-triggered afterglow, which were validated in orthotopic murine models of pancreatic cancer and glioma. By synergizing near-infrared excitation with organic afterglow chemistry, this work overcomes longstanding limitations in penetration depth of excitation light, offering a versatile tool for precision imaging.

Yuzhen Yu, Zhe Li, Shiyi Liao, Baoli Yin, Qingpeng Zhang, Jiaqi Fu, Cheng Zhang, Ying Zhou, Guosheng Song. Enhanced Near-Infrared-Excitable Organic Afterglow Nanoparticles for Deep-Tissue Multimodal Imaging via Singlet Oxygen-Mediated Energy Transfer[J]. Research, 2025 , 8 (8) : 0834 - . DOI: 10.34133/research.0834
Full Text
Less
Introduction
Less
Biomedical imaging technologies, despite their transformative role in diagnostics and research, are constrained by inherent trade-offs [1–12]. Modalities like magnetic resonance imaging (MRI) suffer from limited sensitivity, computed tomography (CT) relies on ionizing radiation, ultrasound is susceptible to gas interference, and fluorescence imaging grapples with tissue autofluorescence [13]. Afterglow imaging, which eliminates the need for real-time excitation to reduce background noise and improve the signal-to-background ratio (SBR), has emerged as a promising imaging modality [14–16]. This technique leverages materials that store excitation energy and emit light persistently post-stimulation, enabling high-contrast visualization of biological targets [17–26]. However, the clinical translation of afterglow imaging remains hindered by critical limitations in existing materials and excitation strategies [27].
Traditional afterglow systems rely on inorganic materials [e.g., ZnGa2(1–x) Cr2xO4, and NaYbF4] [24,25,28–34], in which trapped electrons slowly release energy to produce luminescence. While these materials have demonstrated utility in tumor imaging and cell tracking, their large particle sizes, heavy metal content, and nonbiodegradability pose inignorable biocompatibility risks [30]. Organic afterglow materials, conversely, offer structural tunability, biodegradability, and enhanced biocompatibility [35–37], with applications spanning cancer detection [3,38–40], neuroimaging [41,42], and inflammation monitoring [16,43–45]. Yet, most organic systems depend on visible-light excitation (e.g., white light or 660-nm lasers) [46–49], which restricts tissue penetration depth and limits in vivo signal brightness due to photon scattering and absorption [38,50]. This compromise between excitation depth and afterglow intensity underscores the urgent need for materials that synergize near-infrared excitation—a window with maximal tissue transparency—with high-performance afterglow emission.
Here, we address this challenge by engineering near-infrared-excitable organic afterglow nanoplatform that exploits singlet oxygen (1O2)-mediated energy transfer to achieve deep-tissue activation and prolonged luminescence. The platform integrates two functional components: (a) a near-infrared absorbing molecule (NAM) that generates abundant 1O2 under 808-nm excitation as a photosensitizer, and (b) a triplenet-anthracene derivative (TD) that reacts with 1O2 to produce intense and persistent afterglow. By co-encapsulating NAM and TD into nanoparticles via one-step nanocoprecipitation, we ensure proximity-driven 1O2-mediated energy transfer while minimizing photobleaching. Through systematic screening of nanoplatform and subsequent optimization, the optimal near-infrared-excitable organic afterglow nanoparticles (NOANPs) were successfully engineered. NOANPs exhibited exceptional afterglow brightness (>109 photons/s at 10 μg/ml) and deep-tissue penetration (3.0 cm ex vivo). Furthermore, the nanoparticles offer a unique capability for tri-modal imaging (fluorescence, white light-activated afterglow, and near-infrared-triggered afterglow), as validated in orthotopic models of pancreatic cancer and glioma. This work overcomes barriers in afterglow imaging by marrying near-infrared excitation with organic material design, paving the way for deep-tissue diagnostics and therapeutic monitoring.
Results
Less
Design and characterization of near-infrared-excitable afterglow nanoparticles
To overcome the limitations of the current afterglow systems driven by visible-light pre-irradiation, we engineered a nanoplatform that leveraged singlet oxygen (1O2)-mediated energy transfer for near-infrared-driven afterglow luminescence. The system integrated two functional components: (a) an electron-rich TD, synthesized as the afterglow substrate, and (b) a NAM capable of generating 1O2 as photosensitizer. Co-encapsulation of TD and NAM into nanoparticles via one-step nanocoprecipitation with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy (polyethylene glycol)-2000] (DSPE-PEG2000) ensured proximity between the components, enabling efficient energy transfer (Fig. 1A). 1H nuclear magnetic resonance spectra (1H NMR) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) confirmed successful synthesis of TD (Fig. 1B and Figs. S1 and S2), while ultraviolet–visible and fluorescence spectra revealed a broad absorption peak at 590 nm and emission at 635 nm (Fig. S3), aligning with its role as a visible-light afterglow emitter.
Seven NAMs (NAM-0 to NAM-6) were screened as potential afterglow initiators (Fig. 1B). 1H NMR and MALDI-TOF MS confirmed successful synthesis of NAMs (Figs. S4 to S14) [51–55]. All NAMs exhibited strong near-infrared absorption [720 to 780 nm in tetrahydrofuran (THF); Fig. S15]. These derivatives were converted to water-soluble nanoparticles by DSPE-PEG2000. Notably, NAM-based nanoparticles exhibited redshifted absorption (Δλ = 15 to 100 nm; Fig. 1C and Fig. S16), which enhanced photon capture at 808 nm, making them well suited for 808-nm laser irradiation.
Co-encapsulation of these NAM and TD (TD:NAM = 100:100, μg:μg) via DSPE-PEG2000 yielded water-soluble nanoparticles (denoted as TD@NAM-NPs) with hydrodynamic diameters of 15 to 95 nm (Fig. 1D and Fig. S18) and spherical morphology (Fig. 1E). Moreover, those nanoparticles showed typical absorption spectra of NAM (peak at around 800 nm) and TD (peak at 590 nm) (Fig. 1F).
Screening nanoparticles with optimal afterglow performance and studying afterglow luminescence mechanism
The afterglow performance of the nanoparticles is governed by three key factors—1O2 generation efficiency, 1O2 capture ability, and fluorescence quantum yield [26]. Among these, the ability to generate 1O2 plays an important role in determining afterglow intensity. Afterglow intensity, measured via in vivo imaging system (IVIS) imaging post-near-infrared excitation (808 nm, 50 mW/cm2, 30 s), revealed TD@NAM-0-NPs as the top performer, emitting 2.17 × 108 photons/s—27.1-fold brighter than the weakest candidate (Fig. 2A and B). This superiority correlated with NAM-0’s exceptional 1O₂ generation, validated by singlet oxygen sensor green (SOSG) fluorescence (Fig. 2C and Fig. S19) and 1,3-diphenylisobenzofuran (DPBF) degradation assays (Fig. 2D and Fig. S20). NAM-0-NPs exhibited the fastest SOSG endoperoxide (EPO) formation rate (F/F0 = 1.99 after 180-s irradiation) and 47% DPBF degradation efficiency (after 100-s irradiation), confirming robust reactive oxygen species (ROS) production. In contrast, TA@NAM-5 and TA@NAM-4 exhibit poor 1O2 generation ability, consistent with their weak afterglow signals.
Spectral alignment between TD’s emission (635 nm) and the DsRed/Cy5.5 detection channels (570 to 770 nm) minimized signal loss (Fig. 2E and Fig. S3), while nanoparticle confinement prevented the outward diffusion of 1O2. Theoretical calculations for NAM-0 revealed small energy gaps (ΔES1-T1 = 0.3354 eV, ΔES1-T2 = 0.7038 eV), which are favorable for 1O2 generation (Fig. S21) [56]. To investigate how the TD captures 1O₂ and forms luminescent species, we performed MALDI-TOF MS analysis using a H₂O₂/Na₂MoO₄ system to generate 1O₂. Characteristic peaks corresponding to cycloaddition products between TD and 1O₂ were detected (Fig. S22), indicating the formation of unstable EPOs. Furthermore, incubation of TD-NPs with 1O₂ led to markedly enhanced luminescence compared to phosphate-buffered saline (PBS), H₂O₂, or Na₂MoO₄ alone (Fig. S22) [49]. The afterglow mechanism consists of three phases: (a) Upon 808-nm laser irradiation, the electrons of NAM are excited from the ground state (S0) to the singlet state (S1), followed by intersystem crossing (ISC) to the triplet state (T1). The electrons in the T1 release energy and convert the surrounding 3O2 to 1O2 in the process of returning to the ground state. (b) 1O₂ diffuses into the afterglow substrate TD to form EPOs via cycloaddition. (c) EPOs underwent O–O bond cleavage and decompose, directly emitting photons via chemically initiated electron exchange luminescence (CIEEL) (570 to 770 nm; Fig. 2F).
Rational optimization of near-infrared-triggered afterglow for TD@NAM-0-NPs
To maximize the afterglow performance of TD@NAM-0-NPs under 808-nm excitation, we systematically optimized three critical parameters: the NAM-0-to-TD mass ratio, surfactants, and the surfactant-to-TD mass ratio (Fig. 3A). The NAM-0:TD ratio directly governs the balance between near-infrared-driven 1O₂ generation by NAM-0 and its subsequent trapping by TD to produce afterglow. At suboptimal ratios (NAM-0:TD < 30:100), insufficient 1O₂ generation limits luminescence intensity, while excess NAM-0 (NAM-0:TD > 30:100) likely induces aggregation or self-quenching. The optimal NAM-0/TD ratio of 0.3 (NAM-0:TD = 30:100) achieved a peak afterglow intensity of 3 × 108 photons/s 3-fold brighter than the intensities at ratios of 0.1 (NAM-0:TD = 10:100) or 2.0 (NAM-0:TD = 20:100) (Fig. 3B and C). This balance ensures maximal energy transfer efficiency while maintaining colloidal stability.
Surfactant choice profoundly influences afterglow brightness, as it dictates nanoparticle dispersion and molecular packing. DSPE-PEG2000-coated nanoparticles outperformed styrene maleic anhydride copolymer (PSMA)- and Pluronic-F127-stabilized counterparts by 8× and 30×, respectively (Fig. 3D). DSPE-PEG2000’s long PEG chains likely enhance aqueous stability and prevent 1O₂ diffusion losses [57], whereas PSMA’s shorter chains and F127’s bulkier structure may hinder NAM-0-TD proximity. Further optimization of the DSPE-PEG/TD ratio to 70 (7 mg DSPE-PEG:0.1 mg TD) maximized afterglow output (3 × 108 photons/s) (Fig. 3E and F). Finally, we determined the optimal ratio parameters (TD: 100 μg, NAM: 30 μg, DSPE-PEG: 7 mg) for synthesizing TD@NAM-0-NPs (NOANPs) and utilized them in subsequent experiments.
The 400-fold afterglow enhancement under normoxic versus nitrogen-saturated conditions indicates 1O₂’s indispensable role in the energy transfer cascade (Fig. 3G and H). Control experiments with TD-NPs (TD alone) and NAM-NPs (NAM alone) exhibited negligible afterglow (<1% of NOANPs; Fig. 3I), underscoring the necessity of synergistic NAM-to-TD energy transfer. The 32,714-fold brightness difference between NOANPs and NAM-NPs further highlights the unique ability of TD to capture 1O₂ to produce EPOs and release energy as visible luminescence.
Rational optimization of imaging parameter for NOANPs in solution
To balance afterglow intensity with biosafety for in vivo applications, we systematically optimized excitation parameters for NOANPs. Afterglow signal of 5 μg/ml NOANPs became stronger with the increase of 808-nm laser irradiation time (0 to 100 s; Fig. 4A and B) and reached 3.314 × 108 photons/s at 50 s (0.7-fold versus 100 s). While prolonged excitation (100 s) marginally enhanced intensity (2.2-fold versus 30 s), the 50-s threshold minimized potential photothermal damage while ensuring robust signal generation [58]. Similarly, afterglow intensity increased with laser power (0.1 to 1.0 W/cm2; Fig. 4C and D), yet a pragmatic 0.5 W/cm2 setting was selected to avoid tissue overheating while achieving >70% of peak output [59]. Concentration-dependent studies revealed a direct correlation between nanoparticle density (1 to 20 μg/ml) and afterglow intensity (Fig. 4E and F), with 10 μg/ml yielding exceptional afterglow brightness greater than 109 photons/s (1.76 × 109 photons/s).
NOANPs exhibited sustained afterglow emission for >30 min post-excitation, decaying to 3.5 × 106 photons/s after 60 min (Fig. S23). This excellent persistent afterglow emission is due to the spatial limitations of NAM-0 and TD in the DSPE-PEG2000 matrix, thereby minimizing 1O₂ diffusion loss.
Deep-tissue imaging in tissues
Chicken breast tissue penetration experiments validated NOANPs’ superiority over white light-activated systems (Fig. 5E and F). Due to the afterglow luminescence property of the nanoparticles with 808-nm excitation, it is beneficial to increase the tissue penetration depth. To verify the improved tissue penetration depth, we compared the penetration depth under white light excitation, 808-nm excitation, and fluorescence excitation. The 808-nm excitation exhibits a distinct afterglow signal at 3 cm. However, white light excitation and fluorescence imaging showed the background signal at more than 1.5 cm. Therefore, the afterglow emitted by 808-nm excitation significantly enhances the tissue penetration depth. Since afterglow imaging has a high imaging SBR, we further compared their SBRs. The afterglow triggered by near-infrared (NIR) maintains an SBR of 2.9 at 3.0 cm, which exceeds the afterglow induced by white light (SBR = 1.1). This advantage stems from the absence of autofluorescence during afterglow acquisition with the 808-nm laser.
Subcutaneous tumor and deep-tissue orthotopic tumor imaging by near-infrared activated afterglow
The dual-wavelength strategy (near-infrared excitation/visible emission) synergistically enhances penetration depth. Prior to in vivo application, NOANPs demonstrated exceptional stability across physiological buffers [PBS, Dulbecco’s modified Eagle’s medium (DMEM), RPMI 1640], with hydrodynamic diameters remaining nearly unchanged over 24 h (Fig. S24). This stability, attributed to the DSPE-PEG2000 coating, ensures colloidal integrity in biological environments. Furthermore, afterglow and fluorescence signals remained roughly consistent across buffers (Fig. S25), underscoring robustness for diverse biological applications. Confocal imaging using 2′,7′-dichlorofluorescin diacetate (DCFH-DA) and 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylimidacarbocyanine iodide (JC-1) staining showed that, although NOANPs generate ROS under 808-nm laser irradiation, they do not induce significant mitochondrial dysfunction (Figs. S26 and S27). Moreover, cytotoxicity assay revealed >88% viability in 4T1 cells at concentration of NOANPs up to 200 μg/ml (Fig. S28), confirming its excellent biocompatibility and paving the way for its safe in vivo application.
Due to the good biocompatibility, NOANPs were further validated for in vivo imaging. First, we investigated the effect of different powers on the luminescence. Initial subcutaneous injection of NOANPs in healthy mice validated power-dependent afterglow emission under 808-nm excitation (0.1 to 1.0 W/cm2), mirroring the solution-phase trend of luminescence enhancement with the increase of power (Fig. 6A and Fig. S29). Next, we performed subcutaneous tumor imaging. Benefiting from the nature of near-infrared light excitation of NOANPs, afterglow triggered by 808-nm laser (0.5 W/cm2) exhibited a higher SBR in 4T1 tumor-bearing mice compared to white light afterglow and fluorescence (Fig. 6B to G). This superiority stems from near-infrared light’s deep penetration and absence of autofluorescence, enabling precise tumor delineation. Time-dependent accumulation via the enhanced permeability and retention effect, with SBR reaching 80.8 at 2 h post-injection (Fig. 6G), highlights NOANPs’ capacity for dynamic tumor monitoring. To evaluate the in vivo biodegradability of NOANPs, nanoparticles were intravenously injected into healthy mice. Afterglow signals from major organs were recorded at various time points. Strong afterglow signals were observed in all major organs 2 h after NOANP injection, which gradually decreased to background levels by day 20, indicating effective in vivo biodegradation (Fig. S30).
To address the critical need for deep-tumor detection, the imaging ability of NOANPs was evaluated in the in situ pancreatic cancer and glioblastoma multiforme (GBM) models. The mouse pancreatic cancer model was established by pancreatic in situ implantation of Pan02 cells, and the mouse GBM model was established by implanting C6 cells into the brain. After 1 to 2 weeks, pancreatic and brain tissues from different mouse models were collected and histologically verified through hematoxylin and eosin staining to confirm the presence of tumor lesions (Figs. S31 and S32). In the pancreatic tumor model, obvious afterglow and fluorescence signals were observed 2 h after intravenous injection of NOANPs, and the SBR of 808 nm-induced afterglow reached 26.4 at 2 h, which was higher than that of white afterglow and fluorescence (Fig. 6H and I and Fig. S33). For the challenging deep GBM, obvious fluorescence and afterglow signals were also observed 2 h later, and the SBR of 808 nm-induced afterglow of NOANPs was 48.38 (Fig. 6J and K and Fig. S34), which was higher than that of white light and fluorescence. These results underscore the platform’s ability to overcome photon attenuation in dense tissues, a limitation of conventional visible-light systems.
Discussion
Less
The NOANPs represent a great advancement in afterglow imaging by synergizing near-infrared excitation with organic afterglow chemistry to overcome the penetration depth of excitation light. Conventional afterglow systems, constrained by visible-light excitation (400 to 700 nm), suffer from limited tissue penetration (<1 cm) and autofluorescence interference [38]. By contrast, the 808-nm excitation wavelength of NOANPs exploits the near-infrared-I biological window, enabling deep-tissue activation while minimizing photon scattering. This strategic decoupling of near-infrared excitation and visible-light emission wavelengths circumvents autofluorescence and achieves a 3.0-cm ex vivo penetration depth—3× greater than conventional white light-activated systems.
The nanoparticles’ exceptional performance stems from its rationally designed energy transfer cascade. The near-infrared-photosensitizer NAM-0 generates 1O₂ with high yield, while the electron-rich TD rapidly traps 1O₂ to form EPOs that emit sustained afterglow (>30 min). Crucially, the DSPE-PEG2000 matrix confines NAM-0 and TD within 28-nm nanoparticles, ensuring proximity-driven energy transfer and suppressing 1O₂ leakage. This nanoscale engineering enables NOANPs to deliver bright afterglow (>109 photons/s at 10 μg/ml).
NOANPs’ tri-modal imaging capability (fluorescence, white light-, and near-infrared-triggered afterglow) addresses heterogeneous needs. While fluorescence provides rapid tumor delineation, near-infrared-activated afterglow achieves unmatched specificity in deep tissues, as demonstrated by SBRs in subcutaneous tumors and gliomas higher than white light or fluorescence modes. Moreover, it is important to note that the tissue penetration depth of afterglow luminescence is closely related to the type of the pre-irradiation light source. Generally, longer excitation wavelengths lead to deeper tissue penetration of the afterglow luminescence [14].
Looking ahead, the platform’s modular design invites expansion into theranostics. Conjugating TD@NAM-NPs with targeting ligands (e.g., cRGD for αvβ3-positive tumors) could enhance specificity, while integrating chemotherapeutic cargos (e.g., doxorubicin) may enable real-time treatment monitoring via afterglow signal modulation. Furthermore, the NAM-TD energy transfer framework could be adapted to other ROS-responsive substrates, permitting emission wavelength tuning for multiplexed imaging.
By merging near-infrared optics with organic afterglow mechanisms, this work transcends the limitations of prior systems and establishes a new paradigm for precision imaging. The TD@NAM-NPs not only advance fundamental understanding of energy transfer in nanoconfined systems but also open avenues for translation in intraoperative guidance and metastatic surveillance.
Conclusion
Less
This work establishes a high-performance platform for deep-tissue afterglow imaging through the rational integration of near-infrared-excitable chemistry and organic nanoparticle design. Through systematic optimization, NOANPs with ideal photophysical properties were successfully synthesized. The NOANPs overcome the limitations of conventional afterglow materials by synergizing two critical features: (a) near-infrared-driven activation (808 nm) for enhanced tissue penetration and (b) 1O₂-mediated energy transfer for bright emission (>109 photons/s at 10 μg/ml). By co-encapsulating a near-infrared photosensitizer (NAM-0) and a triplenet-anthracene afterglow substrate (TD) within a DSPE-PEG2000 matrix, we achieve proximity-driven energy transfer while suppressing 1O₂ diffusion losses—a key advancement enabling ultra-bright emission and low photobleaching. The modular design, where NAM-0 and TD serve as interchangeable 1O₂ generator and acceptor units, respectively, provides a generalizable blueprint for tailoring afterglow wavelength and activation parameters. This tunability, combined with the demonstrated 3.0-cm ex vivo penetration depth, positions NOANPs as a versatile tool for imaging deep-seated malignancies.
Methods
Less
The methods can be found in the Supplementary Materials.
Funding
Less
  • National Natural Science Foundation of China(U21A20287)
  • National Natural Science Foundation of China(22404054)
  • National Key Research and Development Program of China(2024YFA1209404)
  • Natural Science Foundation of Hunan Province(2025JJ60076)
  • Changsha Natural Science Foundation(kq2402060)
  • China Postdoctoral Science Foundation(2024M760870)
References
Less
1.
Wang F, Zhong Y, Bruns O, Liang Y, Dai H. In vivo NIR-II fluorescence imaging for biology and medicine. Nat Photonics. 2024;18(6):535–547.
2.
He S, Cheng P, Pu K. Activatable near-infrared probes for the detection of specific populations of tumour-infiltrating leukocytes in vivo and in urine. Nat Biomed Eng. 2023;7(3):281–297.
3.
Xu C, Huang J, Jiang Y, He S, Zhang C, Pu K. Nanoparticles with ultrasound-induced afterglow luminescence for tumour-specific theranostics. Nat Biomed Eng. 2023;7(3):298–312.
4.
Liu Y, Teng L, Liu H-W, Xu C, Guo H, Yuan L, Zhang X-B, Tan W. Recent advances in organic-dye-based photoacoustic probes for biosensing and bioimaging. Sci China Chem. 2019;62(10):1275–1285.
5.
Tan X, Wang Y, Li H, Duan Y, Wen B, Zhao J, Kim H, Lee JY, Zhou L, Cheng H-B, et al.Supramolecular synthesis of dithienylethene-albumin complexes for enhanced photoswitching in photoacoustic imaging-guided near-infrared photothermal therapy. Small. 2025;21(12):Article 2409027.
6.
Zhang S-S, Kim H, Zhou Y, Kang H, Yoon J. Recent developments of small-molecule fluorescent probes for the detection of hydroxyl radical in biological systems. Trend Anal Chem. 2025;185:Article 118165.
7.
Wang J, Zha M, Zhao H, Yue W, Wu D, Li K. Detection of kidney dysfunction through in vivo magnetic resonance imaging with renal-clearable gadolinium nanoprobes. Anal Chem. 2022;94(9):4005–4011.
8.
Lu S-B, Wei L, He W, Bi Z-Y, Qian Y, Wang J, Lei H, Li K. Recent advances in the enzyme-activatable organic fluorescent probes for tumor imaging and therapy. ChemistryOpen. 2022;11(10):Article e202200137.
9.
Lin J, Xing B, Jin D. Optical bioimaging and therapy. Adv Opt Mater. 2023;11(11):Article 2300802.
10.
Lv Z, Jin L, Cao Y, Zhang H, Xue D, Yin N, Zhang T, Wang Y, Liu J, Liu X, et al.A nanotheranostic agent based on Nd3+-doped YVO4 with blood-brain-barrier permeability for NIR-II fluorescence imaging/magnetic resonance imaging and boosted sonodynamic therapy of orthotopic glioma. Light Sci Appl. 2022;11(1):Article 116.
11.
Ye D, Shuhendler AJ, Pandit P, Brewer KD, Tee SS, Cui L, Tikhomirov G, Rutt B, Rao J. Caspase-responsive smart gadolinium-based contrast agent for magnetic resonance imaging of drug-induced apoptosis. Chem Sci. 2014;5(10):3845–3852.
12.
Chen M, Zhou K, Dai S-Y, Tadepalli S, Balakrishnan PB, Xie J, Rami FEI, Dai T, Cui L, Idoyaga J, et al.In vivo bioluminescence imaging of granzyme B activity in tumor response to cancer immunotherapy. Cell Chem Biol. 2022;29(10):1556–1567.e6.
13.
Smith BR, Gambhir SS. Nanomaterials for in vivo imaging. Chem Rev. 2017;117(3):901–986.
14.
Zhu J, Zhao L, An W, Miao Q. Recent advances and design strategies for organic afterglow agents to enhance autofluorescence-free imaging performance. Chem Soc Rev. 2025;54(3):1429–1452.
15.
Li Z, Liu H, Zhang X-B. Reactive oxygen species-mediated organic long-persistent luminophores light up biomedicine: From two-component separated nano-systems to integrated uni-luminophores. Chem Soc Rev. 2024;53(22):11207–11227.
16.
Zhu J, Chen W, Yang L, Zhang Y, Cheng B, Gu W, Li Q, Miao Q. A self-sustaining near-infrared afterglow chemiluminophore for high-contrast activatable imaging. Angew Chem Int Ed Engl. 2024;63(11):Article e202318545.
17.
Jin J, Jiang H, Yang Q, Tang L, Tao Y, Li Y, Chen R, Zheng C, Fan Q, Zhang KY, et al.Thermally activated triplet exciton release for highly efficient tri-mode organic afterglow. Nat Commun. 2020;11(1):Article 842.
18.
Miao Q, Xie C, Zhen X, Lyu Y, Duan H, Liu X, Jokerst JV, Pu K. Molecular afterglow imaging with bright, biodegradable polymer nanoparticles. Nat Biotechnol. 2017;35(11):1102–1110.
19.
Chen C, Zhang X, Gao Z, Feng G, Ding D. Preparation of AIEgen-based near-infrared afterglow luminescence nanoprobes for tumor imaging and image-guided tumor resection. Nat Protoc. 2024;19(8):2408–2434.
20.
Wu L, Ishigaki Y, Hu Y, Sugimoto K, Zeng W, Harimoto T, Sun Y, He J, Suzuki T, Jiang X, et al.H2S-activatable near-infrared afterglow luminescent probes for sensitive molecular imaging in vivo. Nat Commun. 2020;11(1):Article 446.
21.
Wang G, Chen X, Zeng Y, Li X, Wang X, Zhang K. Dual-mechanism design strategy for high-efficiency and long-lived organic afterglow materials. J Am Chem Soc. 2024;146(36):24871–24883.
22.
Liu Y, Teng L, Lou X-F, Zhang X-B, Song G. “Four-in-one” design of a hemicyanine-based modular scaffold for high-contrast activatable molecular afterglow imaging. J Am Chem Soc. 2023;145(9):5134–5144.
23.
le Masne Q, de Chermont CC, Seguin J, Pellé F, Maîtrejean S, Jolivet J, Gourier D, Bessodes M, Scherman D. Nanoprobes with near-infrared persistent luminescence for in vivo imaging. Proc Natl Acad Sci USA. 2007;104(22):9266–9271.
24.
Maldiney T, Bessière A, Seguin J, Teston E, Sharma SK, Viana B, Bos AJJ, Dorenbos P, Bessodes M, Gourier D, et al.The in vivo activation of persistent nanophosphors for optical imaging of vascularization, tumours and grafted cells. Nat Mater. 2014;13(4):418–426.
25.
Li Z, Zhang Y, Wu X, Huang L, Li D, Fan W, Han G. Direct aqueous-phase synthesis of sub-10 nm “luminous pearls” with enhanced in vivo renewable near-infrared persistent luminescence. J Am Chem Soc. 2015;137(16):5304–5307.
26.
Jiang Y, Huang J, Zhen X, Zeng Z, Li J, Xie C, Miao Q, Chen J, Chen P, Pu K. A generic approach towards afterglow luminescent nanoparticles for ultrasensitive in vivo imaging. Nat Commun. 2019;10(1):Article 2064.
27.
Wang X, Pu K. Molecular substrates for the construction of afterglow imaging probes in disease diagnosis and treatment. Chem Soc Rev. 2023;52(14):4549–4566.
28.
Pei P, Chen Y, Sun C, Fan Y, Yang Y, Liu X, Lu L, Zhao M, Zhang H, Zhao D, et al.X-ray-activated persistent luminescence nanomaterials for NIR-II imaging. Nat Nanotechnol. 2021;16(9):1011–1018.
29.
Hu Z, Qu Y, Wang K, Zhang X, Zha J, Song T, Bao C, Liu H, Wang Z, Wang J, et al.In vivo nanoparticle-mediated radiopharmaceutical-excited fluorescence molecular imaging. Nat Commun. 2015;6(1):Article 7560.
30.
Ramírez-García G, Gutiérrez-Granados S, Gallegos-Corona MA, Palma-Tirado L, d’Orlyé F, Varenne A, Mignet N, Richard C, Martínez-Alfaro M. Long-term toxicological effects of persistent luminescence nanoparticles after intravenous injection in mice. Int J Pharm. 2017;532(2):686–695.
31.
Jiang Y, Li Y, Richard C, Scherman D, Liu Y. Hemocompatibility investigation and improvement of near-infrared persistent luminescent nanoparticle ZnGa2O4:Cr3+ by surface PEGylation. J Mater Chem B. 2019;7(24):3796–3803.
32.
Zhao X, Gao X-M, Gu T-Y, Chen K-L, Yan Z-Y, Chen L-J, Yan X-P. Recent advances in stimuli-responsive persistent luminescence nanoparticles-based sensors. Trends Anal Chem. 2023;168:Article 117279.
33.
Shi J, Sun X, Song L, Hong M, Yuan Q, Zhang Y. Inorganic persistent luminescence materials: Emerging optical theranostic agents. Prog Mater Sci. 2024;142:Article 101246.
34.
Zhang Z, Wei Z-J, Sun M, Yan Z, Yin C, Wang W, Yuan Z. A hypochlorite-activatable persistent luminescence nanoprobe for assisted tumor resection. Mater Chem Front. 2024;8(7):1808–1815.
35.
Cui D, Xie C, Li J, Lyu Y, Pu K. Semiconducting photosensitizer-incorporated copolymers as near-infrared afterglow nanoagents for tumor imaging. Adv Healthc Mater. 2018;7(18):Article 1800329.
36.
Xu Y, Yang W, Yao D, Bian K, Zeng W, Liu K, Wang D, Zhang B. An aggregation-induced emission dye-powered afterglow luminogen for tumor imaging. Chem Sci. 2020;11(2):419–428.
37.
Huang W, Zeng W, Huang Z, Fang D, Liu H, Feng M, Mao L, Ye D. Ratiometric afterglow luminescent imaging of matrix metalloproteinase-2 activity via an energy diversion process. Angew Chem Int Ed Engl. 2024;63(26):Article e202404244.
38.
Huang J, Su L, Xu C, Ge X, Zhang R, Song J, Pu K. Molecular radio afterglow probes for cancer radiodynamic theranostics. Nat Mater. 2023;22(11):1421–1429.
39.
Zeng W, Ye D. Seeing cancer via sonoafterglow. Nat Biomed Eng. 2023;7(3):197–198.
40.
Lin Y, Huang J, Liu J, Xu M, Xu C, Pu K. Highly photoreactive semiconducting polymers with cascade intramolecular singlet oxygen and energy transfer for cancer-specific afterglow theranostics. J Am Chem Soc. 2025;147(3):2597–2606.
41.
Zhang F, Yan H, Liu C, Yang Y, Zhang Q, Li Z, Zhang P, Ding C. Mitochondria-targeting near-infrared fluorescence/afterglow sensing assay for the rapid detection of HClO and its application in the early detection of Alzheimer’s disease. Sens Actuators B Chem. 2024;415:Article 135995.
42.
Zhang L, Wang Y-c, Liao Y, Zhang Q, Liu X, Zhu D, Feng H, Bryce MR, Ren L. Near-infrared afterglow ONOO–-triggered nanoparticles for real-time monitoring and treatment of early ischemic stroke. ACS Appl Mater Interfaces. 2023;15(39):45574–45584.
43.
Wang X, Song B, Wang Z, Qin L, Liang W. The innovative design of a delivery and real-time tracer system for anti-encephalitis drugs that can penetrate the blood-brain barrier. J Control Release. 2023;363:136–148.
44.
Zhang H, Lv C, Liu W, Yang M, Du J, Fan J, Peng X. An activatable near-infrared afterglow luminescent nanoprobe with ultralong half-life for in vivo H2S imaging. Chem Eng J. 2024;500:Article 157086.
45.
Liu Y, Teng L, Lyu Y, Song G, Zhang X-B, Tan W. Ratiometric afterglow luminescent nanoplatform enables reliable quantification and molecular imaging. Nat Commun. 2022;13(1):Article 2216.
46.
Wang Y, Shen H, Li Z, Liao S, Yin B, Yue R, Guan G, Chen B, Song G. Enhancing fractionated cancer therapy: A triple-anthracene photosensitizer unleashes long-persistent photodynamic and luminous efficacy. J Am Chem Soc. 2024;146(9):6252–6265.
47.
Ma G, Dirak M, Liu Z, Jiang D, Wang Y, Xiang C, Zhang Y, Luo Y, Gong P, Cai L, et al.Rechargeable afterglow nanotorches for in vivo tracing of cell-based microrobots. Angew Chem Int Ed Engl. 2024;63(18):Article e202400658.
48.
Wang J, Bai L, Huang T, Wang Y, Cheng Z, Liu Q, Su X, Zhao L, Lu F. A singlet oxygen-storing covalent organic framework for “afterglow” photodynamic therapy. J Colloid Interface Sci. 2024;673:679–689.
49.
Wang Y, Guo J, Chen M, Liao S, Xu L, Chen Q, Song G, Zhang X-B. Ultrabright and ultrafast afterglow imaging in vivo via nanoparticles made of trianthracene derivatives. Nat Biomed Eng. 2024;9(5):656–670.
50.
Jiang Y, Pu K. Molecular probes for autofluorescence-free optical imaging. Chem Rev. 2021;121(21):13086–13131.
51.
Luo M, Zhou L, Yuan J, Zhu C, Cai F, Hai J, Zou Y. A new non-fullerene acceptor based on the heptacyclic benzotriazole unit for efficient organic solar cells. J Energy Chem. 2020;42:169–173.
52.
Liu S, Yuan J, Deng W, Luo M, Xie Y, Liang Q, Zou Y, He Z, Wu H, Cao Y. High-efficiency organic solar cells with low non-radiative recombination loss and low energetic disorder. Nat Photonics. 2020;14(5):300–305.
53.
Li Z, Zhu C, Yuan J, Zhou L, Liu W, Xia X, Hong J, Chen H, Wei Q, Lu X, et al.Optimizing side chains on different nitrogen aromatic rings achieving 17% efficiency for organic photovoltaics. J Energy Chem. 2022;65:173–178.
54.
Xu L, Li Z, Ma Y, Lei L, Yue R, Cao H, Huan S, Sun W, Song G. Imaging carotid plaque burden in living mice via hybrid semiconducting polymer nanoparticles-based near-infrared-II fluorescence and magnetic resonance imaging. Research. 2023;6:Article 0186.
55.
Li Z, Zhang N, Chen H, Peng H, Zou Y. Fine-tuning the photovoltaic performance of organic solar cells by collaborative optimization of structural isomerism and halogen atom. Adv Energy Sustain Res. 2022;3(1):Article 2100138.
56.
Yin B, Qin Q, Li Z, Wang Y, Liu X, Liu Y, Huan S, Zhang X, Song G. Tongue cancer tailored photosensitizers for NIR-II fluorescence imaging guided precise treatment. Nano Today. 2022;45:Article 101550.
57.
Li Y, Han R, Zhu B, Wang W, Song Z, Luo X. A nonfouling electrochemical biosensor for protein analysis in complex body fluids based on multifunctional peptide conjugated with PEGlyated phospholipid. ACS Sens. 2024;9(10):5596–5603.
58.
Zeng L, Pan Y, Zou R, Zhang J, Tian Y, Teng Z, Wang S, Ren W, Xiao X, Zhang J, et al.808 nm-excited upconversion nanoprobes with low heating effect for targeted magnetic resonance imaging and high-efficacy photodynamic therapy in HER2-overexpressed breast cancer. Biomaterials. 2016;103:116–127.
59.
Liu C, Liu B, Zhao J, Di Z, Chen D, Gu Z, Li L, Zhao Y. Nd3+-sensitized upconversion metal–organic frameworks for mitochondria-targeted amplified photodynamic therapy. Angew Chem Int Ed Engl. 2020;59(7):2634–2638.
Appendix
Less
Year 2025 volume 8 Issue 8
PDF
10
5
Cite this Article
BibTeX
Article Info
doi: 10.34133/research.0834
  • Receive Date：2025-04-20
  • Online Date：2026-11-01
  • Published：2025-08-20
Article Data
Affiliations
History
  • Received：2025-04-20
  • Revised：2025-07-04
  • Accepted：2025-07-22
Funding
National Natural Science Foundation of China(U21A20287)
National Natural Science Foundation of China(22404054)
National Key Research and Development Program of China(2024YFA1209404)
Natural Science Foundation of Hunan Province(2025JJ60076)
Changsha Natural Science Foundation(kq2402060)
China Postdoctoral Science Foundation(2024M760870)
Affiliations
    State Key Laboratory of Chemo and Biosensing, College of Chemistry and Chemical Engineering, Hunan University, Changsha 410082, China.

Corresponding:

* Address correspondence to: (C.Z.);
(Y.Z.);
(G.S.)
References
Share
https://castjournals.cast.org.cn/joweb/research/EN/10.34133/research.0834
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62662699(Operation and Technical Support)
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House